| Synonyms: | |
| Status: | Approved (2015) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | L01XG03 |
| UNII: | 71050168A2 |
| InChI Key | MXAYKZJJDUDWDS-LBPRGKRZSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H19BCl2N2O4 |
| Molecular Weight | 361.03 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
| Primary Target | |
|---|---|
| proteasome 20S subunit beta 5 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease SK clan
Serine protease S14 family
|
3600 | 5300 | - | - | - | |
|
Enzyme
Protease
Threonine protease
Threonine protease PBT clan
Threonine protease T1A subfamily
|
- | 3-9 | - | - | - | |
|
Enzyme
Protease
Threonine protease
Threonine protease PBT clan
Threonine protease T1B subfamily
|
- | 15 | - | - | - | |
|
Other cytosolic protein
|
- | 6 | - | - | - | |
|
Transcription factor
|
- | 6 | - | - | - | |
|
Unclassified protein
|
- | 15 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Plasmacytoma | 3 | D010954 | ClinicalTrials |
| Amyloidosis, Familial | 3 | D028226 | ClinicalTrials |
| Multiple Myeloma | 3 | D009101 | ClinicalTrials |
| Hematologic Neoplasms | 2 | D019337 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
| Waldenstrom Macroglobulinemia | 2 | D008258 | ClinicalTrials |
| Purpura, Thrombocytopenic, Idiopathic | 2 | D016553 | ClinicalTrials |
| Anemia, Hemolytic, Autoimmune | 2 | D000744 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
| Triple Negative Breast Neoplasms | 1 | D064726 | ClinicalTrials |
| Lupus Nephritis | 1 | D008181 | ClinicalTrials |
| HIV Infections | 1 | D015658 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1072833-77-2 |
| ChEBI | 90942 |
| ChEMBL | CHEMBL2141296 |
| DrugBank | DB09570 |
| DrugCentral | 5067 |
| FDA SRS | 71050168A2 |
| Guide to Pharmacology | 8450 |
| PDB | 6V8 |
| PubChem | 25183872 |
| SureChEMBL | SCHEMBL3742758 |
| ZINC | ZINC000169946773 |